- Report
- February 2026
- 250 Pages
Global
From €4089EUR$4,490USD£3,526GBP
- Report
- August 2025
- 191 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 196 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 195 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 180 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 182 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 188 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 189 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- June 2026
- 194 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 180 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 183 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 184 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 188 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 198 Pages
Global
From €3228EUR$3,545USD£2,784GBP
€3587EUR$3,939USD£3,093GBP
- Report
- January 2026
- 185 Pages
Global
From €4098EUR$4,500USD£3,534GBP
- Report
- November 2025
- 180 Pages
Global
From €4098EUR$4,500USD£3,534GBP
- Report
- February 2026
- 250 Pages
Global
From €4089EUR$4,490USD£3,526GBP
- Report
- February 2026
- 250 Pages
Global
From €4089EUR$4,490USD£3,526GBP
- Report
- February 2026
- 250 Pages
Global
From €4089EUR$4,490USD£3,526GBP
- Report
- February 2026
- 250 Pages
Global
From €4089EUR$4,490USD£3,526GBP

The Cardiac Rhythm Management (CRM) market is a segment of the cardiovascular devices industry. It includes a range of products and services used to diagnose and treat cardiac arrhythmias, or abnormal heart rhythms. These products include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and cardiac ablation systems. CRM products are used to monitor and regulate the electrical activity of the heart, helping to restore normal rhythm and improve patient outcomes.
CRM products are used in a variety of clinical settings, including hospitals, clinics, and ambulatory care centers. The market is driven by technological advancements, such as miniaturization of devices and the development of new features, as well as an increasing prevalence of cardiovascular diseases.
Notable companies in the CRM market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more